Project to Enhance Patient-Health Engagement in HIV Infection
HIV-IN-ACTION
1 other identifier
observational
75
1 country
1
Brief Summary
The importance of patient involvement in their care is emerging as a crucial element in the active management of chronic conditions, including HIV infection. For people living with HIV (PLWH), a proactive role in managing their health promotes improved quality of life and greater adherence to treatment. However, data on enhancing patient engagement among PLWH are currently lacking. This project aims to offer, for the first time, training to enhance patient engagement specifically for PLWH, delivered by psychologists at the Infectious Diseases Outpatient Clinic of the Gemelli Hospital in Rome. The program aims to strengthen emotional, cognitive, and behavioral involvement in the treatment process, promoting greater adherence to treatment, improved management of comorbidities, and increased healthy behaviors. Furthermore, the project aims to adapt the training to the specific needs of PLWH and evaluate its actual impact on quality of life and psychological well-being. Scientific Rationale Over 38 million people are living with HIV worldwide, with approximately 1.5 million new infections in 2021. In Italy, 1,770 new HIV diagnoses were recorded in 2021, with a higher incidence in men between the ages of 30 and 39. Thanks to antiretroviral therapy (ART), AIDS mortality has decreased significantly, and the U=U (Undetectable=Untransmittable) principle has confirmed the importance of virological suppression in reducing virus transmission. Despite the success of ART, one of the current challenges is ensuring a good quality of life for PLWH. HIV management is a chronic process that requires continuity of care, treatment adherence, and a multidisciplinary approach to address emerging comorbidities, including cardiovascular, bone, renal, metabolic, oncological, and neuropsychiatric conditions. In this context, active patient involvement becomes essential to improve adherence to therapy and overall health management.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Nov 2024
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 8, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 6, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
March 19, 2025
CompletedFirst Submitted
Initial submission to the registry
April 30, 2026
CompletedFirst Posted
Study publicly available on registry
May 6, 2026
CompletedMay 6, 2026
April 1, 2026
4 months
April 30, 2026
April 30, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
score of PLWH
to evaluate whether the score of PLWH obtained in the scale measuring engagement increases significantly after the training
10 months
Interventions
develop targeted training that, in addition to promoting greater therapeutic adherence, supports PLWH in improving their quality of life, reducing psychological symptoms and encouraging proactive health behaviors.
Eligibility Criteria
PLWH
You may qualify if:
- Consent to participate in the study
- HIV diagnosis
- Current antiretroviral therapy
- \- Age \>18
- Be able to write, speak, and understand Italian
- Be able to participate in 3 in-person meetings
You may not qualify if:
- Refusal to participate in the study
- No HIV diagnosis
- Not currently receiving antiretroviral therapy
- Not being treated at the Infectious Diseases Outpatient Clinic at the Gemelli Hospital in Rome
- Age \<18 years
- Non-native Italian speaker
- Unable to attend three in-person meetings
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Fondazione Policlinico Universtiario Agostino Gemelli IRCCS
Rome, Roma, 00168, Italy
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Simona Di Giambenedetto
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 30, 2026
First Posted
May 6, 2026
Study Start
November 8, 2024
Primary Completion
March 6, 2025
Study Completion
March 19, 2025
Last Updated
May 6, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will not share